Name | Type | Posted | Actions |
|---|---|---|---|
Exhibit D 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit C 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit B 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit A 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit E 6Mar25.docx | DOCX | Mar 6, 2025 | |
HT940625R0004 Conformed P00003.pdf | Mar 6, 2025 | ||
Exhibit E 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit D 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit C 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit B 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit A 25Feb25.docx | DOCX | Feb 25, 2025 | |
HT940625R0004 Conformed P00002.pdf | Feb 25, 2025 | ||
HT940625R0004 Conformed.pdf | Feb 13, 2025 | ||
Exhibit E.docx | DOCX | Feb 13, 2025 | |
Exhibit D.docx | DOCX | Feb 13, 2025 | |
Exhibit C.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 13, 2025 | |
Exhibit A.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 10, 2025 | |
Exhibit C.docx | DOCX | Feb 10, 2025 | |
Exhibit D.docx | DOCX | Feb 10, 2025 | |
Exhibit E.docx | DOCX | Feb 10, 2025 | |
HT940625R0004.pdf | Feb 10, 2025 | ||
Exhibit A.docx | DOCX | Feb 10, 2025 |
Radiopharmaceuticals - Naval Medical Center Portsmouth
Radiopharmaceuticals - Naval Medical Center Portsmouth
Contact and place of performance
Carol Uebelacker
Portsmouth, VA 23708
USA
Defense Health Agency (DHA) has a requirement for a Firm Fixed Price (FFP) IDIQ supply contract in accordance with FAR Part 12, Commercial Items and FAR Part 13, Simplified Acquisition Procedures for General Nuclear Medicine Radiopharmaceuticals (GNMR) at Naval Medical Center Portsmouth (NMCP) VA. In order to be considered for this requirement, please respond with a completed proposal following the guidelines starting on page 3 of the SF1449.
The Defense Health Agency (DHA) has issued solicitation HT940625R0004 for a firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) supply contract. This requirement provides general nuclear medicine radiopharmaceuticals (GNMR) to support operations at the Naval Medical Center Portsmouth (NMCP) in Portsmouth, Virginia. The acquisition is classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals.
The procurement is conducted in accordance with FAR Part 12 for commercial items and FAR Part 13 for simplified acquisition procedures. Interested parties must submit a completed proposal following the specific guidelines provided in the SF1449 documentation by the response deadline of March 11, 2025. Carol Uebelacker serves as the point of contact for this requirement.
The solicitation includes 24 total attachments, featuring a conformed version of the solicitation and various exhibits updated as of March 6, 2025. These documents include Exhibits A through E and multiple PDF revisions. This notice was originally published on February 10, 2025, and received its most recent update on March 6, 2025.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.